Salubris Biotherapeutics Inc clinical trials
A subsidiary of Shenzhen Salubris Pharmaceuticals Co., Ltd.
The registry lists 6 studies whose lead sponsor is Salubris Biotherapeutics Inc. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 22, 2026.
Registry sponsor names on this page
- Salubris Biotherapeutics Inc6 studies
Something wrong with this grouping? Tell us on the Shenzhen Salubris Pharmaceuticals Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Shenzhen Salubris Pharmaceuticals Co., Ltd. studies →
- Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic CancerRecruitingNCT06667960Phase 1/2
Sponsor listed in the registry: Salubris Biotherapeutics Inc
- Study of JK07 in Patients With Chronic Heart FailureActive, not recruitingNCT06369298Phase 2
Sponsor listed in the registry: Salubris Biotherapeutics Inc
- Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary HypertensionWithdrawnNCT07221513Phase 2
Sponsor listed in the registry: Salubris Biotherapeutics Inc
- Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)CompletedNCT04210375Phase 1
Sponsor listed in the registry: Salubris Biotherapeutics Inc
- Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerActive, not recruitingNCT05620134Phase 1/2
Sponsor listed in the registry: Salubris Biotherapeutics Inc
- Single-Ascending Dose Study of JK07 in Subjects With HFpEFWithdrawnNCT05322616Phase 1
Sponsor listed in the registry: Salubris Biotherapeutics Inc